Background: To investigate the mechanism by which rare cases of spinal local anesthetic (LA) neurotoxicity occur, we have tested the hypotheses that LAs elevate cytoplasmic calcium (Ca 2؉ cyt ), that this is associated with a neurotoxic effect, and that lidocaine and bupivacaine differ in their neurotoxicity.
CLINICAL, 1,2 in vivo, 3 and in vitro 4 studies have documented the occurrence of local anesthetic (LA) spinal neurotoxicity, dependent on both concentration and exposure time, but have not determined the mechanism by which LAs cause neurotoxicity. It is difficult to postulate a mechanism of neural damage based on the primary pharmacologic effect of LAs, block of Na ϩ channels. Blockade of Na ϩ channels and resultant electrical inactivity should decrease neuronal metabolism and preserve ATP. Since export of Ca 2ϩ cyt to the extracellular space is coupled to influx of Na ϩ through the Na ϩ -Ca 2ϩ exchanger, block of Na ϩ channels and maintenance of a low cytosolic Na ϩ should act to prevent elevation of Ca 2ϩ cyt 5 Furthermore, LAs not only block Na ϩ channels, but also block Ca 2ϩ channels at higher concentrations. 6 LAs (at concentrations near therapeutic plasma levels, but much lower than CSF concentrations during spinal anesthesia) limit the increase in Ca 2ϩ cyt caused by agents which cause an influx of Ca 2ϩ through the plasma membrane, in myocardium, 7 airway smooth muscle, 8 and secretory cells. 9 Blockade of Na ϩ influx is protective during neuronal anoxia. 10 LAs are neurotoxic and the chemically dissimilar tetrodotoxin is not when both are given as spinal anesthetics to rats at concentrations that produce similar extents of Na ϩ block. 3 It is therefore most likely that a neurotoxic effect of LAs is mediated by effects other than Na ϩ channel blockade. One potential mechanism is prolonged elevation of Ca 2ϩ cyt , in contrast to the physiologic, fleeting elevation of Ca 2ϩ cyt , which occurs during response to neurotransmitters. 5, [11] [12] [13] Previous studies have suggested a possible detrimental effect of LAs on Ca 2ϩ release from nonmitochondrial intracellular stores. 14 -17 Those studies were limited by being performed on subcellular fragments, rather than on an intact cell with a native intracellular environment. In a glial cell line, lidocaine caused an increase in Ca 2ϩ cyt in cells surrounded by Ca 2ϩ -free buffer, implying release from an intracellular store. 18 In adult dorsal root ganglion neurons, a 30 s pulse of lidocaine transiently increased Ca 2ϩ cyt , deriving from both intracellular and extracellular Ca 2ϩ stores. 19 In the studies reported here, we tested the hypotheses that LAs alter neuronal Ca 2ϩ homeostasis and cause a sustained increase in Ca 2ϩ cyt , that this is associated with a neurotoxic effect, and that lidocaine and bupivacaine differ in their neurotoxicity. We have utilized a cell culture line of healthy sensory neurons to allow assays at the single neuron level, to minimize effects of preparative trauma on Ca 2ϩ cyt and neuronal injury, and to eliminate vascular and other systemic effects of LA. In this model, we have determined the response of neuronal Ca 2ϩ cyt to lidocaine and bupivacaine during a 60 min exposure to clinically relevant concentrations, ranging from that expected with maldistribution and minimal mixing of high concentrations with CSF, to that expected with complete mixing of lower concentrations. We have also determined the incidence of neuronal death during the 60 min exposure.
Materials and Methods

Chemicals and Buffers
All drugs and other chemicals were obtained from Sigma-Aldrich (St. Louis, Missouri), except where specifically noted, and were of the highest purity available. LAs were obtained as their hydrochloride salts, dissolved in buffer, and adjusted to pH 7.4 prior to use. Expressions of percent LA (g/dl) were calculated from the hydrochloride salt weight, consistent with standard clinical usage. Experimental buffer was HEPES-buffered KRH: 5 mM D-glucose; 25 mM HEPES; 115 mM NaCl; 5 mM KCl; 1.2 mM MgSO 4 ; 1.0 mM KH 2 PO 4 ; 2.0 mM CaCl 2 ; ϩNaOH to pH 7.4. 13
Cell Culture
All neuronal studies were conducted using the ND7-104 subclone of the ND7 cell line, obtained from Patrick G. Hogan, Ph.D., Investigator, The Center for Blood Research, Boston, Massachusetts. ND7 was derived from rat dorsal root ganglion, immortalized by fusion with mouse neuroblastoma, and has been extensively characterized as a sensory neuron model. 20 -23 Neuronal cultures were started with an aliquot grown from the original ND7-104 subclone stock, and used for the lesser of 2 months or 8 passages. Proliferation medium for routine cell growth was L-15 (Gibco BRL Life Technologies, Grand Island, New York) supplemented with 3.3 g/l NaHCO 3 , 3.3 g/l d-glucose, and 10% fetal calf serum (FCS; Hyclone; Logan, Utah), in T75 flasks. Neuronal suspensions were prepared by gentle trypsinization (0.05% trypsin ϩ 0.53 mM EDTA) for 3 min, followed by FCS to inhibit further proteolysis, centrifugation at 228 ϫ g for 5 min (Beckman GPR centrifuge; Fullerton, California), resuspension in proliferation medium, and plating on glass coverslips.
Round glass coverslips (Fisherbrand 25CIR-1; Fisher Scientific, Pittsburgh, Pennsylvania) were dipped in 75% ethanol and put with sterile forceps into Falcon tissue culture 35 ϫ 10 mm dishes (BD Biosciences, Franklin Lakes, New Jersey), then exposed to ultraviolet light for 20 min. Poly-D-lysine hydrobromide (Sigma P7405, molecular weight Ͼ 300,000; Sigma-Aldrich, St. Louis, Missouri) 0.1 mg/ml dH 2 O was added, 1.5 ml per dish, and incubated 18 h at room temperature. Each dish was then washed twice with 2 ml sterile dH 2 O, then 1 ml proliferation medium added and the dish and coverslip incubated at 37°C for 30 min. Neurons were then added as a suspension to the coverslip in the tissue culture dish.
Neurons were allowed to attach for 6 h, then the medium was changed to differentiation medium, which is identical to proliferation medium except that FCS was decreased to 0.5%, and 1 mM cyclic adenosine monophosphate (cAMP) and 2 ng/ml nerve growth factor (recombinant rat NGF-␤) were added. This medium was changed daily, and the cells used 48 -72 h after they were initially exposed to differentiation medium. Cells were incubated at 37°C in 6% CO 2 , remainder room air.
Digitized Video Fluorescence Microscopy
We have previously described 13, 24, 25 the imaging system that was used: an Attofluor RatioVision system (Atto Instruments, Rockville, MD) using a Zeiss (Carl Zeiss MicroImaging, Inc., Thornwood, New York) Axiovert 35 M inverted microscope with a Zeiss 40ϫ, 1.30 NA, oil, Plan, Neofluar lens, equipped with an ICCD camera and a temperature controlled stage. The vendor's software was used for defining regions of interest (i.e., single cells), background subtraction, pixel by pixel ratioing and calibration, and gray value reporting of the unprocessed image to insure that the 8 bit dynamic range of the video camera was not exceeded. Neurons were completely shielded from the excitation light except during the fraction of a second when an image was acquired. All experiments were conducted at 37.0 Ϯ 0.3°C.
Neurons were loaded with 5 M fura-2 acetoxymethyl ester (Molecular Probes, Eugene, OR) in KRH ϩ 10% fetal calf serum (FCS) for 20 min at 37°C. This yielded cytoplasmic fura-2: neurons displayed a diffuse, nonpunctate fluorescence throughout the neuron, and lost more than 95% of their fluorescence when exposed to 20 M digitonin, which lyses plasma membrane but not organellar membranes. 26 Excitation was at 334 nm, and 380 nm, with 510 nm dichroic, and 540 Ϯ 25 nm emission. Calculation of Ca 2ϩ cyt from fura-2 fluorescence ratios was performed by calibration with fura-2-free acid solutions containing no Ca 2ϩ (10 mM EGTA) and saturating Ca 2ϩ (2 mM), in 100 mM KCl, 10 mM NaCl, 10 mM MOPS, pH 7.2. 13 Neuronal death was detected by the sudden loss of fura-2 fluorescence from the fluorescent image, indicating loss of plasma membrane integrity, with the lysed neuronal membrane remaining in position on phase contrast view. Dead neurons were excluded from Ca 2ϩ cyt analysis after the time of death. At the time of neuronal death, plasma membrane integrity is lost and there is no longer an effective barrier to the influx of Ca 2ϩ along its large concentration gradient from outside the neuron. Apparent Ca 2ϩ cyt values at this time provide no indication about the role of Ca 2ϩ cyt in leading to neuronal death, but are predictably high as a result of neuronal death.
Following loading with fura-2, any planned pretreatment, and establishment of a stable pre-LA baseline for microscopy experiments, LA was added to yield the final concentration indicated for a given experiment. Images were acquired at a fixed interval for the duration of the experiment, which was planned for 60 min for LA exposure without pretreatment. Control experiments with equimolar concentrations of Tris buffer in place of LA were also performed to control for osmotic and other effects. Tris [(tris-hydroxymethyl)aminomethane] is a commonly used laboratory buffer, with a substituted amine pK a of 8.1 (cf. lidocaine pK a ϭ 7.9, bupivacaine pK a ϭ 8.1).
Statistical Analysis of Changes in Ca 2ϩ cyt
Because such calibrated values of Ca 2ϩ cyt are of highest accuracy in comparing successive values in the same neuron, rather than comparing absolute values between neurons, 27 our experimental protocols were analyzed using the normalized percent change in Ca 2ϩ cyt from the single neuron's baseline before comparing it with other neurons' changes. Initial Ca 2ϩ cyt was 126 Ϯ 13 (SD) nM; N ϭ 967 neurons. Ca 2ϩ cyt concentration at each time point following LA addition for each neuron was normalized by dividing by the average Ca 2ϩ cyt value for that neuron in the 5 min preceding addition of LA. These normalized values were averaged separately for the periods of 0 -10 min, and 10 -60 min (time periods based on initial inspection of data; see Results). Each value was weighted in inverse proportion to the number of neurons observed in a given experiment, so that each experiment had equal weight. Statistical analysis was then performed on the normalized, weighted 0 -10 min, and 10 -60 min, averages of each neuron.
For statistical comparisons between LAs, bupivacaine and lidocaine were compared at equipotent concentrations using a ratio of 1:4; e.g., 0.25% bupivacaine was considered equipotent to, and the same concentration for statistical analysis as, 1% lidocaine. The equimolar Tris buffer controls for bupivacaine and lidocaine were also considered as separate LAs for statistical analysis, and compared with their corresponding equimolar LA concentration; e.g., lidocaine 1% (37 mM) was compared with Tris buffer equimolar (37 mM) to lidocaine 1%.
To determine the effect of concentration, linear regression for each LA was performed separately for 0 -10 min, and 10 -60 min, and for ϪThapsigargin (Tps) and ϩTps.
To determine the effect of LA, analysis of variance was performed at each LA concentration, using LA and Tps as independent variables, and 0 -10 min and 10 -60 min Ca 2ϩ cyt averages as repeated measures dependent variables. Post hoc comparisons within significant effects were performed using the Bonferroni correction.
Survival Analysis
Time of death data from all neurons under a given condition of LA and Tps were combined to produce a single Kaplan-Meier estimator for each condition, and then compared by the Kruskal-Wallis test. All statistical calculations were performed using the algorithms of Systat 7.01 (SPSS Inc., Chicago, Illinois).
Results
Effect of LA on Neuronal Ca 2ϩ
cyt Qualitative Description. Figure 1 illustrates representative single neuron Ca 2ϩ cyt responses to lidocaine
Fig. 1. Effect of lidocaine on neuronal Ca 2؉ cyt : Representative single neuron Ca 2؉ cyt tracings. The asterisk indicates plasma membrane lysis and necrotic cell death for the indicated neuron after exposure to 5% lidocaine, after which Ca 2؉ cyt values are not meaningful because the cytoplasm is in direct communication with extracellular buffer. Note: two-fold expansion of y-axis for each successive graph at lower lidocaine concentrations. Neurons selected for the 5 and 2.5% lidocaine plots represent the lower end of Ca 2؉
cyt values observed for these concentrations, to more clearly illustrate the initial small peak in Ca 2؉ cyt (cf. figs. 3 and 4). The Tris control illustrated was equimolar to 5% lidocaine HCl (i.e., 185 mM). Tris controls for less than 5% lidocaine are omitted for clarity; all were similar to the Tris control illustrated for 5% lidocaine; i.e., flat with minimal increase. Tracings are representative of N ‫؍‬ 5 to 6 experiments for 1.0 -5.0% lidocaine; and of N ‫؍‬ 3 to 4 experiments for 0.1-0.5% lidocaine and for all Tris controls; number of neurons per experiment ‫؍‬ 17 ؎ 5 (SD).
exposures of 60 min. Lidocaine greater than 0.5% caused an initial peak in Ca 2ϩ cyt to approximately twice baseline, which subsided within 10 min. Lidocaine 0.5 and 1.0% returned to near baseline values of Ca 2ϩ cyt after the initial peak. In contrast, lidocaine 2.5% and 5% caused a sustained increase in Ca 2ϩ cyt to toxic levels, with some instances of neuronal death by plasma membrane lysis (necrosis) observed within the 60 min experimental period. Tris controls equimolar to the lidocaine and bupivacaine concentrations tested caused minimal changes in Ca 2ϩ cyt and no neuronal death. Figure 2 illustrates representative single neuron Ca 2ϩ cyt responses to equipotent bupivacaine exposures of 60 min, using a potency ratio of 1:4. Bupivacaine 1.25% (equipotent to 5% lidocaine) could not be tested because it is not soluble at pH 7.4 at 37°C. Bupivacaine greater than 0.125% caused an initial Ca 2ϩ cyt peak similar to that seen with lidocaine, but not a large sustained increase. At the highest bupivacaine concentration that could be tested, 0.625% (19.3 mM), there was generally a slow increase in Ca 2ϩ cyt as illustrated in figure 2 , with a few neurons increasing Ca 2ϩ cyt several-fold over 60 min. No neuronal death was observed for any concentration of bupivacaine during 60 min exposure.
Effect of LA on Neuronal Ca 2ϩ cyt
Quantitative Analysis. Qualitative inspection of individual neuronal tracings (figs. 1 and 2) indicated a biphasic response to local anesthetic: A first phase comprising a small increase in Ca 2ϩ cyt and subsequent decline to near baseline, completed within the first 10 min, and a second phase comprising either a more prolonged, steady increase in Ca 2ϩ cyt for higher concentrations of lidocaine, or a stable maintenance of near baseline Ca 2ϩ cyt for the remainder of the 60 min experimental period. Hence, quantitative analysis of average Ca 2ϩ cyt was performed separately for the time periods of 0 -10 min, and 10 -60 min.
For 0 -10 min, summarized in figure 3, lidocaine 0.1-5% and bupivacaine 0.125-0.625% increased Ca 2ϩ cyt compared with equimolar Tris controls. Lidocaine 1 and 2.5% caused a greater increase than equipotent bupivacaine. The increase with LA concentration was significant by linear regression for both lidocaine and bupivacaine.
For 10 -60 min, summarized in figure 4 , the effect of LA was quite different between low and high concentrations. Ca 2ϩ cyt did not differ from or was less than Tris controls for both lidocaine 1.0% and below and equipotent bupivacaine, and returned to baseline or lower levels. In contrast, lidocaine 2.5 and 5% and bupivacaine 0.625% showed a large increase in Ca 2ϩ cyt during the 10 -60 min period, lidocaine 2.5% more than 0.625% bupivacaine. The increase in Ca 2ϩ cyt with 5% lidocaine was not greater during 10 -60 min than during 0 -10 min. However, this may reflect the limits of Ca 2ϩ cyt monitoring with fura-2. Because the Ca 2ϩ cyt calibration equation is ratiometric, and the K d of fura-2 for Ca 2ϩ is approximately 220 nM, fura-2 begins to saturate and does not accurately report Ca 2ϩ cyt values greater than 1,000 nM. 13 
Origin of Increased Ca 2ϩ cyt Caused by Lidocaine-Effect of Thapsigargin
To test the involvement of the endoplasmic reticulum (ER) in LA-induced Ca 2ϩ cyt increase, neurons were pretreated prior to LA addition with 100 nM thapsigargin (Tps), which releases and depletes ER Ca 2ϩ by inhibiting the ER's ATP-dependent Ca 2ϩ transport. 28 Representative single neuron tracings are depicted in figure 5 , while statistical comparisons of the Ca 2ϩ cyt averages for 0 -10 min and 10 -60 min after LA addition are depicted in figure 6 . As expected, Tps pretreatment caused a transient increase in Ca 2ϩ cyt which returned to a plateau level slightly higher than pre-Tps Ca 2ϩ cyt as Ca 2ϩ cyt released from the ER was transported out of the cell and sequestered in other organelles. Subsequent addition of LA equipotent to lidocaine 1 or 2.5% caused minimal increase in Ca 2ϩ cyt , consistent with the ER being the origin of the initial transient Ca 2ϩ cyt peak seen with these LA concentrations in the absence of Tps. In contrast, Tps pretreatment had no effect on the large increase in Ca 2ϩ cyt caused by 5% lidocaine for 0 -10 min or for 10 -60 min, differing from all the other lidocaine and bupivacaine concentrations tested (although drawing quantitative conclusions from such high Ca 2ϩ cyt values is limited by the measurement range of fura-2, as described previously ["Effect of LA on Neuronal Ca 2ϩ cyt : Quantita-tive Analysis," end of third paragraph]). It is likely that 5% lidocaine still elicited an early Ca 2ϩ release from the ER, since an early peak was often visible in the individual cell tracings ( fig. 1 ), but that its magnitude was quantitatively insignificant compared to the small portion of the later Ca 2ϩ cyt peak which occurred prior to 10 min. Because the initial and later Ca 2ϩ cyt peaks frequently overlapped with 5% lidocaine, and the onset time of the later Ca 2ϩ cyt peak was variable, a greater differentiation between the two peaks was not feasible. A small minority (4/65) of neurons treated with 2.5% lidocaine had a 
Ca 2ϩ
cyt response similar to that with 5% lidocaine. These may represent rare neurons with preexisting injury or senescence, so that they are less able to deal with an increase of Ca 2ϩ cyt . They may also indicate that the dose-response curve for the Tps-independent increase in Ca 2ϩ cyt with lidocaine is fairly steep at 2.5%, with neurons at 2.5% lidocaine very close to responding as they would to 5% lidocaine, and needing only a small impetus from other random variables to push them to that point. Most neurons treated with 2.5% lidocaine had 
. Thapsigargin 100 nM pretreatment is indicated approximately by the arrow, with slight variations in time relative to LA addition between experiments. Ca 2؉ cyt values as graphed are normalized to the baseline value in the 5 min preceding LA addition (i.e., after thapsigargin addition). Note: two y-axes for different magnitudes of Ca 2؉ cyt response between (A) and (B), and two types of Ca 2؉ cyt response (rapid, high and slow, low) to 2.5% lidocaine. The rapid, high Ca 2؉ cyt response to 2.5% lidocaine (A) occurred in 4 out of 65 neurons in three experiments. The slow, low Ca 2؉ cyt response to 2.5% lidocaine (B) occurred in the other 61 neurons. The other tracings were selected from 3 to 4 experiments with greater than 50 neurons total for each LA concentration. Neuronal death occurred before 60 min for all neurons treated with 5% lidocaine, and for the neurons treated with 2.5% lidocaine which had a rapid, high calcium response. In the individual neuron tracings presented, the tracing stops at the time of neuronal death. Lidocaine 1% (59 neurons in 3 experiments) and bupivacaine 0.25% (61 neurons in 3 experiments) had the same pattern as shown for 0.625% bupivacaine and Tris control; i.e., little change in Ca 2؉
cyt after LA addition, and are omitted for clarity. LA concentrations equipotent to lidocaine less than 1% were not tested. 
25% equipotent to 5% lidocaine was not tested because of solubility limits at pH 7.4. Since the purpose of these experiments was to determine the effect of Tps on the perturbation of Ca 2؉
cyt by LA, the only Tris control done for ؉Tps was equimolar to 5% lidocaine (i.e., highest concentration) and is included for illustration only, not for statistical comparisons. Only statistical comparisons specific to Tps are shown on this graph: T ‫؍‬ P < 0.001 ؉ versus ؊ Tps (same LA, concentration, time period); t ‫؍‬ P < 0.01 ؉ versus ؊ Tps (same LA, concentration, time period); ## ‫؍‬ P < 0.001 bupivacaine versus lidocaine (؉Tps; same concentration and time period); # ‫؍‬ P < 0.05 bupivacaine versus lidocaine (؉Tps; same concentration and time period); R ‫؍‬ P < 0.001 0 -10 min versus 10 -60 min (؉Tps; same LA and concentration); shown only on 10 -60 min graph.
an intermediate response: a slow, delayed increase in Ca 2ϩ
cyt of lesser magnitude, doubling or tripling by 60 min, and were viable at 60 min. This suggests that higher concentrations of lidocaine (2.5 and 5%), unlike bupivacaine and the lower concentration of lidocaine tested (1%), increase Ca 2ϩ cyt from a source other than the ER.
Origin of Increased Ca 2ϩ cyt Caused by Lidocaine-Effect of Extracellular Calcium
To test the effect of higher dose LA on Ca 2ϩ influx from extracellular fluid, extracellular buffer was depleted of Ca 2ϩ , neurons exposed to LA, and extracellular buffer then replenished with Ca 2ϩ . Representative single neuron tracings are shown in figure 7 , and quantitative summaries of all experiments in figure 8. In the absence of extracellular Ca 2ϩ , both lidocaine 2.5% and bupiva-caine 0.625% caused a small increase in Ca 2ϩ cyt , indicating that both LAs release Ca 2ϩ from intracellular stores, consistent with the Tps experiments described previously. When Ca 2ϩ was added back to the extracellular buffer (at time 0 in the figure), there was no effect in neurons exposed to bupivacaine. For neurons exposed to lidocaine 2.5% and 5%, however, there was an immediate and sustained ten-fold increase in Ca 2ϩ cyt , suggesting that lidocaine greater than 2.5% causes a large increase in plasma membrane permeability to Ca 2ϩ .
Neuronal Death Caused by Local Anesthetic
The experiments described here are not optimized to study neuronal death, since they follow relatively few numbers of neurons, but to determine quantitative changes in Ca 2ϩ cyt over time in each neuron. Neverthe- less, it is essential to determine the time of death in each neuron in these experiments, because measurement of Ca 2ϩ cyt is meaningful only when neurons have not undergone necrotic death and still have an intact plasma membrane. 13 Survival curves are plotted in figure 9 . Lidocaine 5% by itself caused significant neuronal necrosis within the 60 min protocol period, with a mean survival time of 42 min. Pretreatment with Tps increased neuronal death significantly, with a mean survival time of 15 min. Although neuronal death was observed with 2.5% lidocaine Ϯ Tps, the effect of Tps was not statistically significant at 2.5% lidocaine, and the incidence of neuronal death with 2.5% lidocaine did not differ statistically from Tris controls. No death was observed within 60 min in any experiment with lidocaine less than 1%, bupivacaine less than 0.625%, or Tris control.
Discussion
Our data establish that the highest concentration of lidocaine clinically available (5%) can cause necrotic cell death within 60 min in a neuronal cell culture model. Our data also show that clinical concentrations of lidocaine seen with well-mixed subarachnoid administration, less than 0.5%, 29 do not cause necrotic neuronal death within 60 min nor major alterations in calcium homeostasis, consistent with the clinical experience that the vast majority of lidocaine spinal anesthetics do not cause lasting neural injury. Translation of any cell culture model to the clinical situation is always challenging, because the model does not mimic perfectly the clinical situation. One significant difference of our model from clinical practice is that we maintained a constant concentration of LA during the 60 min exposure period, whereas in vivo the CSF concentration would decrease with time as the LA mixed and diffused out of the CSF. We chose this method to maximize reproducibility with a constant LA concentration, and to model the clinical situation of poor LA mixing that appears to increase risk of neurotoxicity. However, our model may overstate the toxicity that would be seen with a given LA concentration that decreased over time.
A new finding reported here is that both lidocaine greater than 0.5% and bupivacaine greater than 0.125% cause an initial, short-lived (approximately 5 min), moderate increase in Ca. 2ϩ cyt At lower LA concentrations, Ca 2ϩ cyt then returns to normal levels, then decreases below control levels, and death is not observed within our 60 min experimental period. Whether this Ca 2ϩ cyt increase or the subsequent decrease causes any clinically significant effect is unknown. However, there are also known examples of major physiologic changes being triggered by a similar, single, short-lived increase in Ca 2ϩ cyt ; e.g., the metaphase-anaphase transition. 30 Short periods of increased Ca 2ϩ cyt similar to those seen in our experiments (several minutes) can also be associated with synaptic changes affecting neuronal memory and excitability. 31 A speculation which is consistent with the observed occurrence of the clinical syndrome of Transient Neurologic Symptoms (TNS) with low concentrations of lidocaine,(Յ0.5%) 32 and the modulating effects of spinal Ca 2ϩ cyt on pain processing, 33 is that the initial short-lived increase in Ca 2ϩ cyt may initiate a period of increased electrical responsiveness by the neuron, causing hyperalgesia. However, we found no differences between bupivacaine and lidocaine in their effects on Ca 2ϩ cyt at concentrations equipotent to 0.1% and 0.5% lidocaine, and only a small although statistically significant difference at 1% lidocaine, while there is a dramatic difference in clinical incidence of TNS between lidocaine and bupivacaine. 34 The source of the initial short-lived, modest increase in Ca 2ϩ cyt with lidocaine greater than 0.5% and bupivacaine greater than 0.125% appears to be the ER. The ER is a major regulator of Ca 2ϩ cyt , releasing Ca 2ϩ to the cytoplasm or sequestering it in response to multiple stimuli transduced through its IP 3 and ryanodine receptors. Our data are consistent with a large body of work in muscle showing release of Ca 2ϩ from the sarcoplasmic reticulum by LAs, at last partially modulated by the ryanodine receptor, although tissue differences may limit the applicability to neurons. 35, 36 The subsequent large, sustained increase in Ca 2ϩ cyt seen with some neurons exposed to 2.5% lidocaine, and all neurons exposed to 5% lidocaine, does not originate in the ER, but represents influx of Ca 2ϩ cyt from the outside of the neuron through the plasma membrane. Our data do not address whether this is an effect on existing ion channels, or a direct effect on the plasma membrane lipid bilayer, although both are plausible given the known interaction of LAs with multiple ion channels and the amphipathic character of LAs which may affect lipid bilayer permeability. 37 It may be of some concern, and requires further study, that both lidocaine and bupivacaine, at low as well as high concentrations, caused an initial release of Ca 2ϩ from the ER. Recent data have suggested that depletion of ER Ca 2ϩ stores is by itself a severe form of cellular stress, irrespective of Ca 2ϩ cyt levels. 38 Although with our protocol we did not observe necrosis in neurons exposed to lower concentrations of local anesthetic, we cannot exclude the possibility that delayed neuronal death occurred later than 60 min at lower concentrations.
While our data do not yet establish a change in Ca 2ϩ cyt homeostasis as the initial, proximate cause of LA neurotoxicity, our data do establish an important role for the later, sustained increase in Ca 2ϩ cyt in the manifestation of LA neurotoxicity: Ca 2ϩ cyt homeostasis is altered by LAs, the magnitude of alteration parallels the incidence of neuronal death, the incidence of neuronal death increases when the ER is rendered unable to sequester Ca 2ϩ prior to lidocaine treatment, and lidocaine and bupivacaine differ in their effects on Ca 2ϩ cyt . Sustained, high magnitude increases in Ca 2ϩ cyt as seen with 2.5 and 5% lidocaine are generally associated with toxicity. 12, 39 It is probable that a longer exposure or observation time on larger numbers of cells would reveal significant neuronal death with 2.5% lidocaine as well as with 5%. This can better be determined with a different experimental approach (e.g., flow cytometry) than the one chosen here (digitized video fluorescence microscopy), which allows continuous monitoring of a small number of cells.
There was a clear, five-to ten-fold difference between equipotent 2.5% lidocaine and 0.625% bupivacaine in terms of the later, sustained Ca 2ϩ cyt response elicited by the LA, consistent with the greater clinical frequency of serious neural injury after lidocaine than bupivacaine. 2 There was detectable neuronal death with 2.5% lido-caine and not with equipotent 0.625% bupivacaine in our experiments, although the different survival curves were not statistically different during our 60 min protocol. Our inability to compare 5% lidocaine with equipotent bupivacaine illustrates another factor that may be responsible for part or all of the apparent lesser toxicity of bupivacaine clinically: its decreased solubility compared with lidocaine, such that a bupivacaine preparation equipotent to 5% lidocaine is not available and would not be soluble at physiologic pH. Even commercially available 0.75% bupivacaine must be acidified to pH approximately 4 to stay in solution; we cannot consistently prepare solutions of 0.75% bupivacaine without precipitates forming at pH 7.4 at 37°C.
The effect of Tps on neuronal death suggests hypotheses about both the early and late LA-induced Ca 2ϩ cyt peaks. Tps pretreatment eliminated the initial, small, transient Ca 2ϩ cyt peak but did not decrease toxicity, suggesting that the early peak is not associated with acute toxicity within 60 min. This is consistent with our finding that the initial Ca 2ϩ cyt peak was seen with nontoxic concentrations of both lidocaine and bupivacaine. Tps pretreatment increased neuronal death with 5% lidocaine only, and 5% lidocaine was the only LA concentration tested where Tps pretreatment did not decrease Ca 2ϩ cyt ( fig. 6 ), suggesting that the greater than ten-fold late, sustained elevation in Ca 2ϩ cyt seen with 5% lidocaine is mechanistically involved in its neurotoxicity. Tps is quite specific as a tool to deplete ER Ca 2ϩ and determine whether a Ca 2ϩ cyt peak originates from the ER, as the early peak with LA does. However, the effect of Tps is not well localized as a cause of cytotoxicity. Tps has several effects on intracellular Ca 2ϩ homeostasis which by themselves, independent of Ca 2ϩ cyt , can increase toxicity: (1) Tps depletes the ER of Ca 2ϩ28,38 ; (2) By effectively preventing ER uptake of Ca 2ϩ cyt , Tps can increase the demand on other intracellular Ca 2ϩ cyt handling systems, 40 particularly (A) mitochondria, with consequent elevation in mitochondrial Ca 2ϩ and demands on mitochondrial energy stores, and (B) plasma membrane ion pumps, with increased demand for ATP for export of Ca 2ϩ cyt . The late decrease in Ca 2ϩ cyt after the initial increase, seen with 0.5% and 1% lidocaine and equipotent bupivacaine, is consistent with the known Na ϩ and Ca 2ϩ channel blocking properties of lidocaine, and with the protective effect of Na ϩ blockade seen in some models of ischemic neuronal injury. 41, 42 However, a similar decrease was not seen with 0.1% lidocaine, which is still far above the ED 50 for Na ϩ channel block, suggesting that factors other than Na ϩ and Ca 2ϩ channel blockade are responsible.
Our data are generally consistent with those of Gold et al., 19 who used primary cultures of adult rat dorsal root ganglion neurons to assess the neurotoxicity of lidocaine. Their electrophysiologic studies showed that lido-caine greater than approximately 0.25% irreversibly depolarized neurons, consistent with a neurotoxic effect not mediated by Na ϩ channel blockade. They also tested the effect of 30 s pulses of lidocaine on Ca 2ϩ cyt , and the toxicity of a 15 min exposure to lidocaine followed by a 60 min recovery without lidocaine. Lidocaine pulses caused an increase in Ca 2ϩ cyt with an ED 50 of 21 mM (approximately 0.5%) lidocaine. Prolonged monitoring of Ca 2ϩ cyt beyond the 30 s pulse was not done, nor was the effect of bupivacaine assessed. The amplitude of the Ca 2ϩ cyt response to the lidocaine pulse was diminished, but not eliminated, with nominally Ca 2ϩ -free buffer, implicating both intracellular and extracellular Ca 2ϩ as sources of the lidocaine-induced increase in Ca 2ϩ cyt . Gold et al. 19 reported that both 30 mM (0.8%) and 100 mM (2.7%) lidocaine were more toxic than control after 15 min exposure and 60 min recovery, giving 22% and 32% neuronal death, respectively, which is a greater toxicity than we observed. There are two likely reasons for this discrepancy. First is the difference between neuronal cells used. Their primary cultures of acutely isolated DRG neurons were more recently traumatized by dissection and isolation than our continuous cell line. Roughly 7% of the neurons exposed to control by Gold et al. 19 died, versus none of the neurons in our control experiments. Recent studies have documented that axotomy, an inevitable consequence of DRG excision and dissociation, rapidly alters key properties of these neurons. 43 Also, continuous cell lines such as we used tend to be more resistant to many types of injury because they are neoplastic, although this introduces another problem in extrapolating to in vivo neurons. 44 The differences between our toxicity data and that of Gold et al. 19 are consistent with the differences between the neuronal cells used. Although extrapolation from cell culture to in vivo is always difficult, it is reasonable to suggest that the true susceptibility of spinal neurons to lidocaine toxicity in vivo may lie between that of our data and that of Gold et al. 19 Second, Gold et al. 19 reported that significant numbers of neurons exposed to lidocaine lifted from the cover slips they were cultured on and were lost to analysis, making quantitation of cell death problematic. While they partially compensated for this by analyzing the number of dead neurons as a percent of remaining adherent neurons, it is unlikely that the population of neurons that lifted had the same characteristics as the neurons that remained adherent. We also assayed individual neurons under the microscope, but used glass coverslips coated with a substrate of high-density poly-D-lysine, which we have found to maintain adhesion of essentially all neurons for at least 60 min during exposure to lidocaine. We were unable to attain cultures stably adhesive during LA exposure using collagen or poly-DL-ornithine with or without laminin or other protein supplementation. This is in itself most likely an indication of LA toxicity, as rounding of cells and detachment from substratum attachment are typical, nonspecific indicators of acute cellular injury. 45, 46 In conclusion, lidocaine is clearly neurotoxic and elevates Ca 2ϩ cyt to toxic levels at clinically available concentrations which might be achieved with poor CSF mixing, in a neuronal cell culture model which eliminates vascular and other systemic effects. Lower concentrations of lidocaine and all concentrations of bupivacaine alter Ca 2ϩ cyt homeostasis for several minutes, but without an immediate neurotoxic effect within 60 min. Both LAs initially release Ca 2ϩ from the ER, but only lidocaine 2.5% or 5% also causes a sustained influx of Ca 2ϩ through the plasma membrane.
